Local Legal Representative and Compliance Support for Pharma across Europe
In-market presence without in-country headcount.
Local legal representative support for pharma must reflect each country’s requirements and the activities being undertaken. Eunomia provides named in-market compliance support, local-code interpretation and market-entry assessments, with the required mandate and responsibilities agreed for each engagement.
Discuss this service
The challenge
Connect global standards to local responsibilities
A global policy does not resolve every country-level question. Market entry and cross-border activities can leave teams unsure which requirements apply, who should review an activity and where responsibility sits. We help define the local support and escalation routes needed for the planned activity.
Who this service is for
For pharmaceutical and biotech teams entering a market, working across borders or operating with limited local compliance capacity. Support is scoped to the countries, activities and responsibilities involved, rather than assuming the same representation model fits every market.
How delivery works
We assess the market-entry context, identify relevant local requirements and agree named contacts and decision rights. Support can include code interpretation, association liaison, HCP engagement review and transparency processes. Any representative role and its responsibilities are confirmed for the specific engagement.
What we can take on
Local Legal Mandates and Representation: scope of support
Local code interpretation and queries
Association liaison and self-regulatory filings
Cross-border HCP engagement review
Market-entry compliance assessment
Local transparency and disclosure requirements
What this gives you
Local context brought into global processes
Clear ownership and escalation by market
Faster market entry without unnecessary fixed overhead
Why Eunomia
Expertise connected to delivery
Our local compliance partners connect country knowledge with your central team. Agreed reporting and escalation routes help local decisions fit the wider compliance programme. Country guides and team biographies provide a starting point for discussing the expertise your engagement needs.
Meet your compliance specialists →Related cross-market case study
One FMV method, with country-specific inputs
The five-market FMV project combined a common calculation framework with national data and stakeholder-specific rate cards. It illustrates a cross-market approach to compliance delivery, rather than a case study of a statutory representative appointment.
Read the case study →How an engagement runs
From scope to working process
- 01
Define the activity
Confirm the countries, planned activities and the entities and people involved.
- 02
Map local requirements
Identify the national law and industry code that apply, and where they differ from your global policy.
- 03
Agree responsibilities
Confirm named contacts, decision rights, review routes and any formal role for the engagement.
- 04
Operate and escalate
Review activities as they arise and escalate questions through the agreed routes to your central team.
The rules behind this service
Frameworks we work to
Local support sits between European frameworks and national rules. These are the European layers; our country guides cover the national detail.
Start here
EU Directive 2001/83/EC
The EU code for medicinal products for human use, including the advertising and inducement framework that national laws implement.
Official source: Directive 2001/83/ECEFPIA Code of Practice
Sets European standards for interactions with healthcare professionals, healthcare organisations and patient organisations, including annual disclosure of transfers of value within six months of the end of each calendar year. Member associations transpose it into national codes and may adopt stricter standards.
Official source: EFPIA CodeUK Bribery Act 2010, section 7
A commercial organisation can be liable for failing to prevent bribery by persons associated with it, such as agents and service providers. Having adequate procedures in place is a defence.
Official source: Bribery Act, s.7Informational summary, not legal advice. Sources checked September 2026.
Named local expertise
Local context, connected globally.
Explore our coverage. Select a red partner marker to open that compliance officer's biography on the Team page.
Hover over Europe to zoom in. Hover over a red dot to see a photo; click to read their bio.On mobile, tap “Zoom Europe”, then tap a red dot to read their bio. Red dots show team member locations.
Rashmi Papneja — United Kingdom — United Kingdom Compliance LeadMaria Diaz — Spain — Global Compliance Business PartnerDr. Hans Joachim Hutt — Germany — Global Compliance Business Partner — DACHAlexandre Guillaume — France — Global Compliance Business Partner — Global & FranceJalmira Mulchande — Portugal — Global Compliance Business PartnerIlaria Franchini — Italy — Global Compliance Business PartnerDunja Hu — Austria — Global Compliance Business PartnerMiroslaw Zapala — Poland, Ukraine & Russia — Global Compliance Business PartnerKaren Glade — United States & Canada — Global Compliance Business PartnerMohamed Afir — MENA — Global Compliance Business PartnerNishant Chaturvedi — APAC — Global Compliance Business PartnerRohit Kumar — APAC — Global Compliance Business Partner
Service coverageHover or tap a team marker to meet your compliance partner.Europe · MENA · US · Brazil & South America · India · Southeast Asia · Japan
Legal mandates
Designed around the rules that sit behind the process…
We map legal and self-regulatory requirements into practical controls, review routes, evidence and ownership.
Anti-bribery and corruption
UK Bribery Act 2010—including section 7 failure to prevent and its broad territorial reach—plus the FCPA and OECD Anti-Bribery Convention.
Promotion of medicines
EU Directive 2001/83/EC, including the advertising and inducement framework for medicinal products.
National anti-gift and benefit rules
Country-specific requirements including French DMOS as amended by Ordonnance 2017-49, Portuguese INFARMED rules, and relevant Greek, Turkish and Polish regimes.
Failure to prevent fraud
The ECCTA 2023 offence, in force since 1 September 2025—a live control gap in many pharmaceutical third-party frameworks.
Transparency and disclosure
US Sunshine Act / Open Payments, France’s Loi Bertrand, Danish and Portuguese registers, plus the code-based EFPIA disclosure layer—translated into data, process and reporting controls.
EU AI Act and related regulation
Regulation (EU) 2024/1689, read alongside the GDPR, EU Data Act and, where AI forms part of a medical device or diagnostic, the MDR and IVDR—covering risk classification, data governance, transparency, human oversight, technical documentation, post-market monitoring and accountability.
Primary references
This overview is informational and does not constitute legal advice. Scope and application should be confirmed for the organisation, market, activity and counterparty in question.
Questions, answered
Local Legal Mandates and Representation FAQs
What does local compliance representation mean?
It means providing a named, market-aware compliance contact who can interpret local requirements, support queries and connect local obligations to your global governance model.
Which markets can Eunomia support?
Coverage includes EU5, more than 20 European markets, MENA, the United States, South America and Asia. Exact scope is confirmed for each engagement.
Can you interpret country-specific industry codes?
Yes. Support can cover local legal requirements, industry codes, association expectations and the practical implications for activities and documentation.
Do we need to open a local office?
Not necessarily. The appropriate model depends on the legal obligation and activity, but many compliance-support and representation needs can be met without permanent local headcount.
Can you support cross-border HCP engagements?
Yes. We can identify relevant home- and host-country requirements, establish the review route and document the rationale and approvals.
How does local support connect to our global team?
Named contacts, decision rights, escalation paths and reporting are agreed so local advice feeds into a consistent global operating model.
Tell us what is on your desk.
We will listen, ask a few questions and recommend the right scope—without obligation or pressure.
Start a conversation